Revisiting the Duration of Vasomotor Symptoms of Menopause: A Meta-Analysis
- 429 Downloads
Treatment decisions about menopause are predicated on a transient duration of vasomotor symptoms. However, evidence supporting a specific duration is weak.
To estimate the natural progression of vasomotor symptoms during the menopause transition by systematically compiling available evidence using meta-analytic techniques.
We searched MEDLINE, hand searched secondary references in relevant studies, book chapters, and review papers, and contacted investigators about relevant published research.
English language, population-based studies reporting vasomotor symptom prevalence among women in menopausal transition in time intervals based on years to or from final menstrual period were included. Two reviewers independently assessed eligibility and quality of studies and extracted data for vasomotor symptom prevalence.
The analyses included 10 studies (2 longitudinal, 8 cross sectional) with 35,445 participants. The percentage of women experiencing symptoms increased sharply in the 2 years before final menstrual period, peaked 1 year after final menstrual period, and did not return to premenopausal levels until about 8 years after final menstrual period. Nearly 50% of all women reported vasomotor symptoms 4 years after final menstrual period, and 10% of all women reported symptoms as far as 12 years after final menstrual period. When data were examined according to symptom severity (‘any’ vs. ‘bothersome’), bothersome symptoms peaked about 1 year earlier and declined more rapidly than symptoms of any severity level.
Our findings suggest a median symptom duration of about 4 years among symptomatic women. A longer symptom duration may affect treatment decisions and clinical guidelines. Further prospective, longitudinal studies of menopausal symptoms should be conducted to confirm these results.
KeywordsHormone Therapy Menopausal Symptom Symptom Duration Menopausal Hormone Therapy Vasomotor Symptom
This work was supported by the Agency for Healthcare, Research, and Quality (AHRQ) 2R01 HS013329-04A1. An earlier version was presented at the Society for Medical Decision Making Annual Meeting, October 2007. We would like to thank Nancy Avis, Ph.D. (Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC), Janet Guthrie, M.Sc., Dip. Ed, Ph.D. (Center for Women’s Health, University of Melbourne, Australia), and Martha Hickey, M.D. (School of Women’s and Infants’ Health, University of Western Australia, Australia) for their thoughtful reviews of this manuscript.
Conflict of Interest
- 3.Lobo R (ed). Treatment of the postmenopausal woman: Basic and clinical aspects.: Academic Press; 2007.Google Scholar
- 4.Medical Knowledge Self Assessment Program 14. 2007.Google Scholar
- 9.Women’s Health Initiative. Scientific Resources Website. Vol. 2006.Google Scholar
- 14.National Institute of Health. NIH State-of-the-Science conference on management of menopause-related symptoms. Vol. 2005; 2005.Google Scholar
- 16.Medical Women’s Federation. An investigation of the menopause in one thousand women. The Lancet. 1933:106–108.Google Scholar
- 18.Kronenberg F. Hot Flashes. New York: Raven Press, Ltd.; 1994:97.Google Scholar
- 19.Association for Healthcare Research and Quality. Evidence report/Technology assessment: Management of menopause-related symptoms. Vol. 2005; 2005.Google Scholar
- 20.Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000.Google Scholar
- 29.Melby MK. Vasomotor symptom prevalence and language of menopause in Japan. Menopause: The Journal of the North American Menopause Society. 2005;12(3):250–7.Google Scholar
- 34.Ford K, Sowers MF, Crutchfield M, Wilson A, Jannausch M. A longitudinal study of the predictors of prevalence and severity of symptoms commonly associated with menopause. Menopause: The Journal of the North American Menopause Society. 2005;12(3):308–17.Google Scholar
- 36.Lau J. Metaanalyst. Boston, MA, US.Google Scholar
- 38.Kaufert P, Syrotuik J. Symptom reporting at the menopause. Soc Sci Med. 1981;15(3):173–84.Google Scholar
- 42.Keenan NL, Mark S, Fugh-Berman A, Browne D, Kaczmarczyk J, Hunter C. Severity of menopausal symptoms and use of both conventional and complementary/alternative therapies. Menopause: The Journal of the North American Menopause Society. 2003;10(6):507–15.Google Scholar
- 47.Huang AJ, Grady DG, Blackwell TL, Bauer DC, Sawaya GF. Persistent hot flashes in older postmenopausal women (abstract). J Gen Intern Med. 2007;22(suppl 1):168.Google Scholar